Abstract:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) keeps evolving and mutating into newer variants over time, which gain higher transmissibility, disease severity, and spread in communities at a faster rate, resulting in multiple waves of surge in Coronavirus Disease 2019 (COVID-19) cases. A highly mutated and transmissible SARS-CoV-2 Omicron variant has recently emerged, driving the extremely high peak of infections in almost all continents at an unprecedented speed and scale. The Omicron variant evades the protection rendered by vaccine-induced antibodies and natural infection, as well as overpowers the antibody-based immunotherapies, raising the concerns of current effectiveness of available vaccines and monoclonal antibody-based therapies. This review outlines the most recent advancements in studying the virology and biology of the Omicron variant, highlighting its increased resistance to current antibody-based therapeutics and its immune escape against vaccines. However, the Omicron variant is highly sensitive to viral fusion inhibitors targeting the HR1 motif in the spike protein, enzyme inhibitors, involving the endosomal fusion pathway, and ACE2-based entry inhibitors. Omicron variant-associated infectivity and entry mechanisms of Omicron variant are essentially distinct from previous characterized variants. Innate sensing and immune evasion of SARS-CoV-2 and T cell immunity to the virus provide new perspectives of vaccine and drug development. These findings are important for understanding SARS-CoV-2 viral biology and advances in developing vaccines, antibody-based therapies, and more effective strategies to mitigate the transmission of the Omicron variant or the next SARS-CoV-2 variant of concern.

Parallel profiling of antigenicity alteration and immune escape of SARS-CoV-2 Omicron and other variants

Understanding the Secret of SARS-CoV-2 Variants of Concern/Interest and Immune Escape

Predicting the immune escape of SARS-CoV-2 neutralizing antibodies upon mutation

Molecular Insights into Striking Antibody Evasion of SARS-CoV-2 Omicron Variant

SARS-CoV-2 Omicron variant: Immune escape and vaccine development

The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron

Potential immune evasion of the severe acute respiratory syndrome coronavirus 2 Omicron variants

Distinct Patterns of SARS-CoV-2 BA.2.87.1 and JN.1 Variants in Immune Evasion, Antigenicity and Cell-Cell Fusion

SARS-COV-2 Omicron variants conformationally escape a rare quaternary antibody binding mode

Comprehensive Deep Mutational Scanning Reveals the Immune-Escaping Hotspots of SARS-CoV-2 Receptor-Binding Domain Targeting Neutralizing Antibodies

Comprehensive structural analysis reveals broad-spectrum neutralizing antibodies against SARS-CoV-2 Omicron variants

Immune Evasion of Neutralizing Antibodies by SARS-CoV-2 Omicron.

Antibody evasion properties of SARS-CoV-2 Omicron sublineages

Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2

Molecular basis of receptor binding and antibody neutralization of Omicron

Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron

SARS-CoV-2 Omicron: Viral Evolution, Immune Evasion, and Alternative Durable Therapeutic Strategies

Cross-species tropism and antigenic landscapes of circulating SARS-CoV-2 variants

Broadly SARS-CoV-2 aptamers overcome variant antigenic shift

Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages

Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances to Counter the SARS-CoV-2 Omicron Variant